ViiV’s Bid To Switch HIV Patients To Cabenuva Boosted By Biktarvy Head-To-Head
90% Of Participants Happy With Switch
Cabenuva is the first long-acting HIV therapy, an approach which is expected to dominate in the coming decades. • Source: Image: Shutterstock 
